Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott R Barnum

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Journal of Innate Immunity|February 10, 2015
C4a: An Anaphylatoxin in Name OnlyScott R Barnum
Pharmacology & Therapeutics|December 5, 2016
Complement: A primer for the coming therapeutic revolutionScott R Barnum
Trends in Pharmacological Sciences|April 18, 2017
Therapeutic Inhibition of Complement: Well Worth the RiskScott R Barnum
Immunologic Research|October 31, 2002
Complement in central nervous system inflammationScott R Barnum
Frontiers in Immunology|August 1, 2020
Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic OptionPhilip F Stahel, Scott R Barnum
Journal of Neuropathology and Experimental Neurology|August 18, 2005
Complement as a biomarker in multiple sclerosisScott R Barnum, Alexander J Szalai
Brain Research Reviews|January 31, 2006
Complement and demyelinating disease: no MAC needed?Scott R Barnum, Alexander J Szalai
Journal of Neuroscience Research|March 3, 2004
Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitisAlexander J Szalai, Scott R Barnum
Journal of Leukocyte Biology|October 12, 2007
Differential expression of beta 2-integrins and cytokine production between gammadelta and alphabeta T cells in experimental autoimmune encephalomyelitisSherry S Smith, Scott R Barnum
Molecular Immunology|October 28, 2008
Nylon wool purification alters the activation of T cellsJillian E Wohler, Scott R Barnum
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Journal of Innate Immunity|February 10, 2015
C4a: An Anaphylatoxin in Name OnlyScott R Barnum
Pharmacology & Therapeutics|December 5, 2016
Complement: A primer for the coming therapeutic revolutionScott R Barnum
Trends in Pharmacological Sciences|April 18, 2017
Therapeutic Inhibition of Complement: Well Worth the RiskScott R Barnum
Immunologic Research|October 31, 2002
Complement in central nervous system inflammationScott R Barnum
Frontiers in Immunology|August 1, 2020
Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic OptionPhilip F Stahel, Scott R Barnum
Journal of Neuropathology and Experimental Neurology|August 18, 2005
Complement as a biomarker in multiple sclerosisScott R Barnum, Alexander J Szalai
Brain Research Reviews|January 31, 2006
Complement and demyelinating disease: no MAC needed?Scott R Barnum, Alexander J Szalai
Journal of Neuroscience Research|March 3, 2004
Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitisAlexander J Szalai, Scott R Barnum
Journal of Leukocyte Biology|October 12, 2007
Differential expression of beta 2-integrins and cytokine production between gammadelta and alphabeta T cells in experimental autoimmune encephalomyelitisSherry S Smith, Scott R Barnum
Molecular Immunology|October 28, 2008
Nylon wool purification alters the activation of T cellsJillian E Wohler, Scott R Barnum
Pageof 8